Search - tctmd.com

Displaying 21 - 40 of 573

Sort: Relevancy | Date

Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors

News Daily News

Subclinical Atherosclerosis Evident in Half of Adults Without CVD Risk Factors

Michael O'Riordan

December 12, 2017

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

News Daily News

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

December 12, 2017

Hospital Mortality for Patients With A-fib Higher in Rural Areas

News Daily News

Hospital Mortality for Patients With A-fib Higher in Rural Areas

December 11, 2017

Attacking DVT With Drug-Device Combo Does Not Reduce Postthrombotic Syndrome

News Daily News

Attacking DVT With Drug-Device Combo Does Not Reduce Postthrombotic Syndrome

December 08, 2017

Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US

News Daily News

Hospital Readmission Patterns Post-MI in China Differ Markedly From in the US

Yael L. Maxwell

December 07, 2017

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

News Daily News

Surviving CVD: Obesity Offers No Protection for Those With New Onset Cardiac Events

Michael O'Riordan

December 07, 2017

Diabetes Remission Possible With Significant Weight Loss: DiRECT

News Daily News

Diabetes Remission Possible With Significant Weight Loss: DiRECT

Michael O'Riordan

December 05, 2017

News Industry News

Baim Institute Names Dr. C. Michael Gibson As CEO

December 05, 2017

Dreams Dashed: Intravascular Therapy for MS Flops in Sham-Controlled Trial

News Daily News

Dreams Dashed: Intravascular Therapy for MS Flops in Sham-Controlled Trial

December 05, 2017

Some Concerns About New ‘Tour de Force’ Hypertension Guidelines

News Daily News

Some Concerns About New ‘Tour de Force’ Hypertension Guidelines

December 04, 2017

Burden of Readmission High in PAD Patients Following Revascularization

News Daily News

Burden of Readmission High in PAD Patients Following Revascularization

December 04, 2017

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

News Daily News

It’s Official: Evolocumab Gains Claim for CVD Event Reduction

Michael O'Riordan

December 04, 2017

ACC Provides Guidance on How to Manage Bleeding in Patients Taking Oral Anticoagulants

News Daily News

ACC Provides Guidance on How to Manage Bleeding in Patients Taking Oral Anticoagulants

December 04, 2017

Discrepant FFR and iFR Results May Signal Low MACE Risk in Deferred Lesions

News Daily News

Discrepant FFR and iFR Results May Signal Low MACE Risk in Deferred Lesions

December 01, 2017

More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine

News Daily News

More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine

Yael L. Maxwell

December 01, 2017

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

News Daily News

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

November 30, 2017

Genetic Study Hints at Role of Lipids in AAA Risk

News Daily News

Genetic Study Hints at Role of Lipids in AAA Risk

Michael O'Riordan

November 30, 2017

A Visit With a Cardiologist May Improve A-fib Outcomes

News Daily News

A Visit With a Cardiologist May Improve A-fib Outcomes

November 28, 2017

Nephroprotective NOACs? Renal Dysfunction Not Infrequent Among A-fib Patients, but Some Agents Reduce Risk

News Daily News

Nephroprotective NOACs? Renal Dysfunction Not Infrequent Among A-fib Patients, but Some Agents Reduce Risk

Yael L. Maxwell

November 28, 2017

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.